The DOI matches its Crossref record; 130 of the 131 references it cites were found in a registry or an index.
Molecular Genetics of Late‐Onset Alzheimer's Disease
Open accessAbstract
Summary: Late‐onset Alzheimer's disease (AD) is a complex and multifactorial disease with the possible involvement of several genes. Apolipoprotein E (APOE), especially the APOE*4 allele, has been established as a strong susceptibility marker that accounts for nearly 30% of the risk in late‐onset AD. However, as the APOE*4 allele is neither necessary nor sufficient for the development of AD, it emphasizes the involvement of other genetic and/or environmental factors which, alone or in conjunction with APOE*4, can modify the risk of AD. Recently, genome‐wide linkage or linkage disequilibrium studies on late‐onset AD have provided informative data for the existence of multiple putative genes for AD on several chromosomes, with the strongest evidence on chromosomes 12, 10, 9 and 6. This paper attempts to review the current progress on the identification of additional genetic loci for late‐onset AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The APOE polymorphism is the most studied, successfully replicated, and well-established risk factor for AD where APOE*2 is the protective allele and APOE*4 is the risk allele as compared to APOE*3 [7–10].”
From Genome-wide analysis identifies novel loci influencing plasma apolipoprotein E concentration and Alzheimer’s disease risk (2023) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sørlie, T., Perou, C. M., Tibshirani, R. J., Aas, T., Geisler, S. B., Johnsen, H., Hastie, T. J., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 11,506
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Candidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577
Exploring the new world of the genome with DNA microarrays
Brown, P. O., & Botstein, D. (1999) · Nature Genetics · doi:10.1038/4462 · Cited by 2,430
Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., et al. (1995) · Nature · doi:10.1038/376775a0 · Cited by 2,052
Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F. (1998) · Nature · doi:10.1038/34910 · Cited by 1,818
Berge, K. E., Tian, H., Graf, G. A., Yu, L., Grishin, N. V., Schultz, J. R., Kwiterovich, P. O., Shan, B., Barnes, R., & Hobbs, H. H. (2000) · Science · doi:10.1126/science.290.5497.1771 · Cited by 1,645
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611
Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils
Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526
Research works printed but not linked: 4
- Holmans P., 2003, Evidence of interaction between susceptibility loci on chromosomes 1, 10 and 12 in late‐onset Alzheimer's disease (LOAD), Am J Hum Genet, 73, 184
- Roses A. D., 1995, Alzheimer's disease as a model of molecular gerontology, J NIH Res, 7, 51
- Stanton K. C., 2003, Further evidence of linkage of Alzheimer's disease on chromosome 12, Am J Hum Genet, 73, 471
- Xu P.‐T., 2002, Characterization and analyses of AD candidate genes P16 and MTAP on chromosome 9p21, Am J Hum Genet, 71, A490
Cited by
Sorted by citations
Items 101–169 of 169
Roes, M., & Galea, L. A. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-802114-9.00009-3 · Cited by 15
Is the ornithine transcarbamylase gene a genetic determinant of Alzheimer’s disease?
Hansmannel, F., Lendon, C. L., Pasquier, F., Dumont, J., Hannequin, D., Chapuis, J., Laumet, G. O., Ayral, A., Galimberti, D., Scarpini, E. A., et al. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.10.081 · Cited by 14
Moscarillo, T. J., Holt, H. L., Perman, M., Goldberg, S., Cortellini, L., Stoler, J. M., DeJong, W., Miles, B., Albert, M., Go, R. C. P., et al. (2007) · Public Health Genomics · doi:10.1159/000099087 · Cited by 14
Expression of the Newly Identified Gene CAC1 in the Hippocampus of Alzheimer’s Disease Patients
Kong, Y., Bai, P., Sun, H., & Nan, K. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9717-5 · Cited by 14
A multigenerational pedigree of late-onset Alzheimer's disease implies new genetic causes
Jiménez‐Escrig, A., Gómez‐Tortosa, E., Baron, M., Rábano, A., Arcos‐Burgos, M., Palacio, L. G., Yusta, A., Anta, P., Perez, I., Hierro, M., et al. (2005) · Brain · doi:10.1093/brain/awh501 · Cited by 14
Kopel, J. J., Sehar, U., Choudhury, M., & Reddy, P. H. (2023) · Healthcare · doi:10.3390/healthcare11060868 · Cited by 15
Su, F., Shu, H., Ye, Q., Xie, C., Yuan, B., Zhang, Z., & Bai, F. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160787 · Cited by 13
APOE2 and Consanguinity: A risky combination for Alzheimer's disease
Kaur, M., & Balgir, P. P. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-8308 · Cited by 13
A novel gene derived from a segmental duplication shows perturbed expression in Alzheimer’s disease
Avramopoulos, D., Wang, R., Valle, D. L., Fallin, M. D., & Bassett, S. S. (2007) · Neurogenetics · doi:10.1007/s10048-007-0081-5 · Cited by 12
Does APOE explain the linkage of Alzheimer's disease to chromosome 19q13?
Blom, E. S., Holmans, P., Arepalli, S., Adighibe, O., Hamshere, M. L., Gatz, M., Pedersen, N. L., Bergem, A. L. M., Owen, M. J., Hollingworth, P., et al. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30681 · Cited by 13
Wang, H., Hsiao, C., Hsieh, A., Lin, Y., & Fann, C. S. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040996 · Cited by 10
Perry, R. T., Wiener, H. W., Harrell, L. E., Blacker, D., Tanzi, R. E., Bertram, L., Bassett, S. S., & Go, R. C. P. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30433 · Cited by 11
Gene-environment interplay in neurogenesis and neurodegeneration
Palomo, T., Archer, T., Beninger, R. J., & Kostrzewa, R. M. (2004) · Neurotoxicity Research · doi:10.1007/bf03033279 · Cited by 11
Hewlings, S. J., Draayer, K., & Kalman, D. (2021) · Nutrients · doi:10.3390/nu13041127 · Cited by 10
Environmental Enrichment can Prevent Cognitive Decline Induced by Dietary Oxidative Challenge
Lee, S., Doulames, V. M., Donnelly, M., Levasseaur, J., & Shea, T. B. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111562 · Cited by 10
Miller, A., Desai, A., Roley, L. T., Goodwin, R. L., Imeh‐Nathaniel, A., & Nathaniel, T. I. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1052330 · Cited by 9
Chuang, Y., Varma, V. R., An, Y., Tanaka, T., Davatzikos, C. A., Resnick, S. M., & Thambisetty, M. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191335 · Cited by 8
Genética de las enfermedades neurodegenerativas más prevalentes
Lladó, A., Gaig, C., & Molinuevo, J. L. (2006) · Medicina Clínica · doi:10.1157/13087844 · Cited by 9
Molecular Approaches, Models, and Techniques in Pharmacogenomic Research and Development
Mu, W., & Zhang, W. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-391918-2.00008-1 · Cited by 11
Assessing Alzheimer’s Disease and Dementia: Best Practices in Nursing Care
Ganzer, C. A. (2007) · Geriatric Nursing · doi:10.1016/j.gerinurse.2007.10.008 · Cited by 9
Vogler, G. P. (2006) · Elsevier eBooks · doi:10.1016/b978-012101264-9/50006-9 · Cited by 7
No association of dynamin binding protein (DNMBP) gene SNPs and Alzheimer's disease
Minster, R. L., DeKosky, S. T., & Kamboh, M. I. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.010 · Cited by 7
Self-citationBaye, T. M., Perry, R. T., Wiener, H. W., Chen, Z., Harrell, L. E., & Go, R. C. P. (2008) · Disease Markers · doi:10.1155/2008/736409 · Cited by 7
Absence of Relationship Between MTTP Haplotypes and Longevity
Neville, M. J., Clarke, R., Evans, J. G., Rubinsztein, D. C., & Karpe, F. (2007) · The Journals of Gerontology Series A · doi:10.1093/gerona/62.2.202 · Cited by 6
Pan, X., Coban‐Akdemir, Z., Gao, R., Jiang, X., Sheynkman, G., Wu, E., Huang, J. H., Sahni, N., & Yi, S. S. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad030 · Cited by 6
Pattern Separation: A Key Processing Deficit Associated with Aging?
Gilbert, P. E., Holden, H. M., Sheppard, D. P., & Morris, A. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-15759-7_5 · Cited by 6
Genetics and Dementia Nosology
Blacker, D., & Lovestone, S. (2006) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988706291091 · Cited by 6
Lack of association of two chromosome 10q24 SNPs with Alzheimer's disease
Minster, R. L., DeKosky, S. T., & Kamboh, M. I. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.08.081 · Cited by 6
Self-citationNCRAD: Advancing Alzheimer's research through high‐quality biospecimens and data
Edler, M. C., Faber, K., Lacy, K., Jackson, J. M., & Foroud, T. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.70682 · Cited by 4
Apolipoprotein E3 as a Risk Factor for Alzheimer's Disease Under Conditions of Nutritional Imbalance
Chan, A., & Shea, T. B. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100060 · Cited by 5
While I Still Remember: 30 Years of Alzheimer’s Disease Research
Shea, T. B. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170724 · Cited by 5
Genetics of Alzheimer's Disease
Bekris, L. M., Yu, C., Bird, T. D., & Tsuang, D. W. (2010) · Wiley eBooks · doi:10.1002/9780470669600.ch43 · Cited by 6
A deep belief network-based method to identify proteomic risk markers for Alzheimer diseasePreprint
An, N., Jin, L., Ding, H., Yang, J., & Yuan, J. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2003.05776 · Cited by 6
Genetics of A lzheimer's Disease
Brookes, K. J., & Morgan, K. (2017) · Wiley eBooks · doi:10.1002/9780470015902.a0020228.pub2 · Cited by 6
DeKosky, S. T., & López, O. L. (2007) · Blue books of neurology · doi:10.1016/s1877-184x(09)70053-x · Cited by 5
Chuo, L.-J., Wu, S.-T., Chang, H., & Kuo, Y. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.03.061 · Cited by 4
Influência genética sobre a doença de Alzheimer de início tardio
Barros, A. C., Lucatelli, J. F., Maluf, S. W., & de Andrade, F. M. (2009) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832009000100003 · Cited by 4
Shea, T. B. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.07.039 · Cited by 3
Biogenesis and regulation of microRNA: implication in Alzheimer‘s disease
Mouton‐Liger, F., Paquet, C., & Hugon, J. (2010) · Future Neurology · doi:10.2217/fnl.10.58 · Cited by 3
Genetic Testing For Neurological Disorders
NANCE, M. A. (2005) · Neurological disease and therapy · doi:10.1201/9780849358364.ch2 · Cited by 3
Srivastava, K., & Srivastava, R. (2025) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2025.2597291 · Cited by 2
Masoumi, S. J., Haghani, M., Mokkaram, P., Firoozi, D., Mortazavi, S. A. R., Ardekani, F. M., Ardekani, A. T., & Mortazavi, S. M. J. (2021) · Journal of Biomedical Physics and Engineering · doi:10.31661/jbpe.v0i0.2104-1318 · Cited by 2
Genética y enfermedad de Alzheimer: población en riesgo
Fernández‐Viadero, C., Rodríguez‐Rodríguez, E., Pascual, O. C., & Santiago, D. C. (2013) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2012.03.004 · Cited by 1
Genetic and Environmental Factors in Neurodegenerative Diseases
Coppedè, F., & Migliore, L. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50144-7 · Cited by 1
Biotecnología en salud: versiones y dimensiones
Reza, R., & Teresa, M. (2011) · Revista Colombiana de Biotecnología · Cited by 1
Mitochondrial DNA variation in extremely selected traits: longevity and elite athletic performance
Niemi, A. (2005) · Cited by 1
Shea, T. B., Rogers, E. J., & Remington, R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407824-6.00077-x · Cited by 1
Genetics, Alzheimer’s disease and Down syndrome
Schupf, N. (2018) · CRC Press eBooks · doi:10.1201/9781315376875-3 · Cited by 1
Genetic Factors in Alzheimer Disease and Dementia
Bird, T. D. (2009) · Springer eBooks · doi:10.1007/978-3-540-37654-5_28 · Cited by 1
Alzheimer Disease, Genetics of
Kehoe, P. G. (2008) · Wiley eBooks · doi:10.1002/9780470015902.a0020228 · Cited by 1
Koutseff, A. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique)
Genetic variability commonly affecting neurodegeneration and neuroinflammation
Ström, M. (2012) · Figshare
Endosomes élargis et cholestérol : De la trisomie 21 à la maladie d'Alzheimer
Cossec, J. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique)
Identification of novel target genes for the plasticity-related transcription factor Zif268
McDade, D. M. (2007) · Enlighten: Theses (The University of Glasgow)
Hollingworth, P. (2006) · ORCA Online Research @Cardiff (Cardiff University)
Murtishaw, A. S. (2020) · Digital Scholarship - UNLV (University of Nevada Reno) · doi:10.34917/6456429
Biswas, S., & Papachristou, C. (2010) · Human Heredity · doi:10.1159/000298285
Regional Differences in Diagnostic Conversion to Dementia
Galkina, E. I., & Grinstein, G. (2014) · International Conference on Information Visualisation (IV) · doi:10.1109/iv.2014.67
Genetic dissection of models for neuroinflammation and neurodegeneration
Harnesk, K. (2009) · Figshare
Molecular changes during the development of Alzheimer's disease
Wirz, K. T. S. (2013) · Data Archiving and Networked Services (DANS)
outcome of Alzheimer's disease Interleukin-18 gene polymorphisms predict risk and
Caltagirone, C., Federici, G., Trequattrini, A., Macciardi, F. M., Spoletini, I., Ciaramella, A., Moro, M. L., & Bellincampi, L. (2007)
A CANDIDATE GENE STUDY OF LATE-ONSET ALZHEIMER'S DISEASE
Burns, L. C. (2010) · D-Scholarship@Pitt (University of Pittsburgh)
Approach for Alzheimer's Disease
Tian, H. (2014)
Hendricks, E. W. (2015) · Journal of Collective Bargaining in the Academy
Tirniceriu, A. (2009) · DuEPublico (University of Duisburg-Essen)
Wright, C. I., Trinh, N., Blacker, D., & Falk, W. E. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04743-2.50021-4
Abbate, C., Arosio, B., Cantatore, A., Viti, N., Giunco, F., Bagarolo, R., Nicolini, P., Gussago, C., Ferri, E., Casati, M., et al. (2015) · Aging Clinical and Experimental Research · doi:10.1007/s40520-015-0383-7
Role of apolipoprotein E4 in alzheimer’s disease pathogenesis and emerging therapeutic strategies
Natarajan, S., & Saraswathy, S. D. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01761-0
Metadata
- Authors
- Kamboh, M. I.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Kamboh, M. Ilyas
- ORCID
- Kamboh, M. Ilyas
- Venue
- Annals of Human Genetics
- Publisher
- Wiley
- Published
- 2004-06-28
- Volume
- 68
- Issue
- 4
- Pages
- 381-404
- ISSN
- 0003-4800 (ISSN-L)
- 1469-1809
- OpenAlex
- W2137932456
- Cited by
- 170
- References
- 131
- Citations by year
- 2025: 4 · 2024: 2 · 2023: 4 · 2022: 2 · 2021: 6 · 2020: 4 · 2019: 1 · 2018: 1 · 2017: 5 · 2016: 7 · 2015: 4 · 2014: 7 · 2013: 6 · 2012: 12
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Annals of Human Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG 05-133, P50AG005133, AG13672, R01AG013672)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- late-onset Alzheimer's disease, apolipoprotein E, genetic susceptibility, genetic loci, genome-wide linkage analysis, linkage disequilibrium, complex diseases, genetic risk factors
- MeSH terms
- Alzheimer Disease, Apolipoproteins E, Humans, Genetic Linkage, Molecular Biology, Biomarkers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review